Panion & Bf Biotech Inc.

Taiwan Stock Exchange 1760.TW

Panion & Bf Biotech Inc. Price to Earnings Ratio (P/E) on January 14, 2025: 84.14

Panion & Bf Biotech Inc. Price to Earnings Ratio (P/E) is 84.14 on January 14, 2025, a -26.70% change year over year. Price to earnings ratio compares the stock price to earnings per share; higher P/E suggests expectations for future earnings growth.

Panion & Bf Biotech Inc. 52-week high Price to Earnings Ratio (P/E) is 120.11 on April 03, 2024, which is 42.76% above the current Price to Earnings Ratio (P/E).
Panion & Bf Biotech Inc. 52-week low Price to Earnings Ratio (P/E) is 83.10 on January 13, 2025, which is -1.23% below the current Price to Earnings Ratio (P/E).
Panion & Bf Biotech Inc. average Price to Earnings Ratio (P/E) for the last 52 weeks is 99.79.

Key data

Date	Price to Earnings Ratio (P/E)	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)	Dividend Yield

Taiwan Stock Exchange: 1760.TW

Panion & Bf Biotech Inc.

CEO	Mr. Tsung-Ming Chiang
IPO Date	Dec. 20, 2007
Location	Taiwan
Headquarters	Building F
Employees	321
Sector	Health Care
Industries Biotechnology Cosmetics Pharmaceuticals

Description

Panion & Bf Biotech Inc., a biotechnology pharmaceutical company, manufactures and sells various pharmaceutical products in Taiwan. The company offers products in the areas of medical beauty, kidney, respiratory tract, gastrointestinal tract, and body and hair cleaning. It also provides oral drugs and topical preparations; hand and mechanical disinfection, body lotion, and skin disinfection products; and pet health products, including surgical and skin prescriptions. Panion & Bf Biotech Inc. was founded in 1976 and is headquartered in Taipei, Taiwan.

Key trends

Past 5 years